Anna Erdei

6.8k total citations
176 papers, 4.8k citations indexed

About

Anna Erdei is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anna Erdei has authored 176 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Immunology, 59 papers in Molecular Biology and 59 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anna Erdei's work include Complement system in diseases (60 papers), Monoclonal and Polyclonal Antibodies Research (59 papers) and T-cell and B-cell Immunology (39 papers). Anna Erdei is often cited by papers focused on Complement system in diseases (60 papers), Monoclonal and Polyclonal Antibodies Research (59 papers) and T-cell and B-cell Immunology (39 papers). Anna Erdei collaborates with scholars based in Hungary, Austria and United States. Anna Erdei's co-authors include Zsuzsa Bajtay, József Prechl, Péter Somogyi, Botond Penke, I.W. Chubb, A.J. Hodgson, Manfred P. Dierich, Noémi Sándor, Thomas F. Schulz and Fritz Melchers and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Anna Erdei

175 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Erdei Hungary 36 2.5k 1.3k 703 666 494 176 4.8k
Jürgen Roes United Kingdom 30 4.0k 1.6× 2.5k 1.9× 738 1.0× 559 0.8× 519 1.1× 43 7.9k
Mario Mellado Spain 49 4.5k 1.8× 2.7k 2.0× 648 0.9× 575 0.9× 378 0.8× 122 8.3k
Peter N. Monk United Kingdom 44 2.6k 1.0× 2.1k 1.6× 411 0.6× 771 1.2× 516 1.0× 127 6.2k
Barry G.W. Arnason United States 46 2.0k 0.8× 1.2k 0.9× 1.0k 1.4× 717 1.1× 387 0.8× 157 6.6k
Takaharu Okada Japan 39 5.2k 2.1× 2.5k 1.8× 778 1.1× 370 0.6× 409 0.8× 69 8.9k
Wilfred A. Jefferies Canada 43 2.6k 1.0× 2.2k 1.6× 368 0.5× 487 0.7× 981 2.0× 109 6.5k
Darren A. Thompson United States 33 2.6k 1.0× 1.6k 1.2× 369 0.5× 272 0.4× 392 0.8× 59 6.1k
Georges Bismuth France 47 3.4k 1.4× 2.2k 1.6× 528 0.8× 333 0.5× 195 0.4× 132 6.1k
Toshiyuki Tanaka Japan 42 2.5k 1.0× 2.0k 1.5× 372 0.5× 254 0.4× 379 0.8× 229 6.1k
Rolf Bräuer Germany 38 2.0k 0.8× 1.1k 0.8× 339 0.5× 371 0.6× 858 1.7× 108 5.3k

Countries citing papers authored by Anna Erdei

Since Specialization
Citations

This map shows the geographic impact of Anna Erdei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Erdei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Erdei more than expected).

Fields of papers citing papers by Anna Erdei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Erdei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Erdei. The network helps show where Anna Erdei may publish in the future.

Co-authorship network of co-authors of Anna Erdei

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Erdei. A scholar is included among the top collaborators of Anna Erdei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Erdei. Anna Erdei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdei, Anna, et al.. (2021). New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4. Immunology Letters. 237. 42–57. 30 indexed citations
2.
Péter, Beatrix, Imre Boldizsár, Gábor M. Kovács, et al.. (2021). Natural Compounds as Target Biomolecules in Cellular Adhesion and Migration: From Biomolecular Stimulation to Label-Free Discovery and Bioactivity-Based Isolation. Biomedicines. 9(12). 1781–1781. 8 indexed citations
3.
Lukácsi, Szilvia, et al.. (2020). Utilization of complement receptors in immune cell–microbe interaction. FEBS Letters. 594(16). 2695–2713. 24 indexed citations
5.
Uzonyi, Barbara, Szilvia Lukácsi, Katalin Török, et al.. (2017). Functional studies of chronic lymphocytic leukemia B cells expressing β 2 -integrin type complement receptors CR3 and CR4. Immunology Letters. 189. 73–81. 9 indexed citations
7.
Mészáros, Tamás, Barbara Uzonyi, Mario Hebecker, et al.. (2015). Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro. Nanomedicine Nanotechnology Biology and Medicine. 12(4). 1023–1031. 25 indexed citations
8.
Kövesdi, Dorottya, et al.. (2014). Coadministration of antigen-conjugated and free CpG: Effects of in vitro and in vivo interactions in a murine model. Immunology Letters. 160(2). 178–185. 7 indexed citations
9.
Erdei, Anna, et al.. (2014). Introduction. Immunology Letters. 160(2). 107–108. 1 indexed citations
10.
Hős, Csaba, Norbert Orgován, Beatrix Péter, et al.. (2014). Single Cell Adhesion Assay Using Computer Controlled Micropipette. PLoS ONE. 9(10). e111450–e111450. 34 indexed citations
11.
Kacskovıcs, Imre, Judit Cervenak, Anna Erdei, Richard A. Goldsby, & John E. Butler. (2011). Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies. mAbs. 3(5). 431–439. 17 indexed citations
12.
Mihaylova, Nikolina, Ivan Grozdev, Marta Baleva, et al.. (2011). Elimination of autoreactive B cells in humanized SCID mouse model of SLE. European Journal of Immunology. 41(11). 3301–3311. 16 indexed citations
13.
Muha, Villő, Ibolya Leveles, Éva Hunyadi‐Gulyás, et al.. (2007). A novel fruitfly protein under developmental control degrades uracil-DNA. Biochemical and Biophysical Research Communications. 355(3). 643–648. 20 indexed citations
14.
Markiewski, Maciej M., Dimitrios C. Mastellos, Ruxandra Tudoran, et al.. (2004). C3a and C3b Activation Products of the Third Component of Complement (C3) Are Critical for Normal Liver Recovery after Toxic Injury. The Journal of Immunology. 173(2). 747–754. 148 indexed citations
15.
Bajtay, Zsuzsa, Cornelia Speth, Anna Erdei, & Manfred P. Dierich. (2004). Cutting Edge: Productive HIV-1 Infection of Dendritic Cells via Complement Receptor Type 3 (CR3, CD11b/CD18). The Journal of Immunology. 173(8). 4775–4778. 72 indexed citations
16.
Bánki, Zoltán, Laco Kacani, Brigitte Müllauer, et al.. (2003). Cross-Linking of CD32 Induces Maturation of Human Monocyte-Derived Dendritic Cells Via NF-κB Signaling Pathway. The Journal of Immunology. 170(8). 3963–3970. 51 indexed citations
17.
Kacani, Laco, Zoltán Bánki, Jörg Zwirner, et al.. (2001). C5a and C5adesArg Enhance the Susceptibility of Monocyte-Derived Macrophages to HIV Infection. The Journal of Immunology. 166(5). 3410–3415. 45 indexed citations
18.
Erdei, Anna, Gábor Tóth, János Matkó, et al.. (1999). Inhibition of IgE-mediated triggering of mast cells by complement-derived peptides interacting with the FcεRI. Immunology Letters. 68(1). 79–82. 14 indexed citations
19.
Kacani, Laco, Georg Mathias Sprinzl, Anna Erdei, & M. P. Dierich. (1999). Interleukin-15 Enhances HIV-1-Driven Polyclonal B-Cell Response in vitro. PubMed. 16(3). 162–172. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026